Durga Venkatalaksh Madala, MD
Cardiovascular Disease (Cardiology) · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 5 carriers
- Office
- 1
Offices
1 location · Durga Madala M D Inc · 2 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital · Hazel Hawkins Memorial Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
21 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Madala’s office at (408) 356-4242 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A56316 · Current
Licensed to practise in California · since 1996 · expires 2028-06-30 · University of Health Sciences, Vijayawada, Guntur Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Hazel Hawkins Memorial HospitalHollister, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Hazel Hawkins Memorial Hospital
Behind the star rating — Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.1) · 409 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 43 cases | No different | Jan 2024 – Dec 2024 |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$1,078,277
Medicare paid this office $1,078,277 for 1,894 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 1,520 | $366,144 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,178 | $257,183 | $198 |
| Ultrasound of both sides of head and neck blood flow | 649 | $128,768 | $197 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 156 | $71,817 | $460 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 258 | $59,339 | $227 |
See all 25 services
| Return visit (30+ min) | 1,520 | $366,144 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,178 | $257,183 | $198 |
| Ultrasound of both sides of head and neck blood flow | 649 | $128,768 | $197 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 156 | $71,817 | $460 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 258 | $59,339 | $227 |
| New patient visit (45+ min) | 199 | $30,208 | $152 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,170 | $23,534 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $22,899 | $106 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 63 | $18,985 | $297 |
| Telephone medical discussion with physician, 5-10 minutes | 240 | $14,380 | $53 |
| New patient visit (60+ min) | 75 | $12,422 | $166 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $11,621 | $143 |
| Programming of dual lead pacemaker system | 104 | $10,967 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 166 | $10,495 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 93 | $8,776 | $88 |
| Short return visit (20+ min) | 101 | $7,732 | $74 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 70 | $4,530 | $61 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 156 | $3,432 | $11 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $3,092 | $124 |
| Injection, regadenoson, 0.1 mg | 136 | $2,978 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 57 | $1,629 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 173 | $1,260 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,125 | $94 |
| Infusion, normal saline solution, 250 cc | 156 | $271 | None |
| Injection, aminophyllin, up to 250 mg | 30 | $189 | None |
Who their Medicare patients are
1,894 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 19% · Women 61% · Also on Medicaid 6% · Health risk score 1.20. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 66% · Diabetes 41% · Atrial fibrillation 24% · Heart failure 20% · Chronic kidney disease 20% · Cancer 18% · Depression 14% · COPD 12% · Stroke 12% · Dementia 8%.
The office billed $3,664,310, Medicare allowed $1,424,339 and paid $1,078,277; for 10,659 services of 47 kinds; $3,438 of it was for drugs given in the office and $1,074,839 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,894 | 10,659 | 77 | 1.20 | $3,664,310 | $1,078,277 |
| 2023 | 1,714 | 9,053 | 77 | 1.20 | $1,995,916 | $778,202 |
| 2022 | 1,655 | 9,541 | 77 | 1.23 | $1,795,629 | $762,890 |
| 2021 | 1,573 | 9,319 | 77 | 1.23 | $1,679,489 | $749,402 |
| 2020 | 1,359 | 8,125 | 77 | 1.40 | $1,460,538 | $618,615 |
| 2019 | 1,417 | 8,618 | 77 | 1.38 | $1,378,279 | $570,061 |
| 2018 | 1,284 | 8,212 | 77 | 1.31 | $1,278,816 | $493,809 |
| 2017 | 1,108 | 7,807 | 77 | 1.38 | $1,189,085 | $475,966 |
| 2016 | 941 | 6,337 | 77 | 1.31 | $879,162 | $350,408 |
| 2015 | 865 | 6,816 | 77 | 1.30 | $1,029,828 | $427,774 |
| 2014 | 774 | 6,753 | 76 | 1.21 | $1,037,935 | $433,316 |
| 2013 | 698 | 7,518 | 76 | 1.24 | $989,668 | $401,938 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 980 | $206,241 | $191 |
| Return visit (30+ min) | 997 | $161,331 | $110 |
| Short return visit (20+ min) | 926 | $100,393 | $84 |
| Ultrasound of both sides of head and neck blood flow | 348 | $69,193 | $197 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 125 | $58,103 | $461 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 246 | $56,353 | $229 |
| New patient visit (45+ min) | 227 | $32,788 | $144 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,146 | $22,024 | $13 |
| Injection, regadenoson, 0.1 mg | 103 | $18,127 | None |
| Programming of dual lead pacemaker system | 108 | $12,172 | $73 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 127 | $9,281 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 128 | $8,051 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $7,415 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,794 | $152 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 78 | $1,721 | $22 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 55 | $1,482 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 195 | $1,432 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,370 | $62 |
| Heart rhythm recording of continous external ekg over 8-15 days | 77 | $937 | $12 |
| Injection, aminophyllin, up to 250 mg | 89 | $660 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $507 | $23 |
| Infusion, normal saline solution, 250 cc | 126 | $457 | None |
2022: 23 services
| Return visit (30+ min) | 1,113 | $216,461 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 866 | $184,350 | $194 |
| Short return visit (20+ min) | 723 | $74,858 | $83 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 129 | $63,252 | $483 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 243 | $54,615 | $225 |
| Ultrasound of both sides of head and neck blood flow | 221 | $43,752 | $198 |
| New patient visit (45+ min) | 207 | $29,883 | $144 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,198 | $25,285 | $13 |
| Injection, regadenoson, 0.1 mg | 113 | $22,312 | None |
| Programming of dual lead pacemaker system | 107 | $12,567 | $74 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 125 | $11,897 | $47 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 103 | $6,606 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 75 | $3,398 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $3,004 | $26 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 115 | $2,613 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 114 | $1,493 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 186 | $1,479 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $860 | $32 |
| Injection, aminophyllin, up to 250 mg | 113 | $853 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $749 | $23 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 22 | $606 | $28 |
| Infusion, normal saline solution, 250 cc | 129 | $517 | None |
| Blood test, clotting time | 14 | $513 | $4 |
2021: 24 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 812 | $177,158 | $203 |
| Return visit (30+ min) | 907 | $171,644 | $116 |
| Short return visit (20+ min) | 820 | $94,544 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 135 | $69,900 | $518 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 215 | $51,199 | $235 |
| New patient visit (45+ min) | 234 | $35,749 | $153 |
| Ultrasound of both sides of head and neck blood flow | 156 | $32,392 | $208 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,165 | $27,987 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 130 | $23,364 | $90 |
| Injection, regadenoson, 0.1 mg | 102 | $19,428 | None |
| Programming of dual lead pacemaker system | 131 | $18,269 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 114 | $7,397 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 75 | $4,227 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 58 | $3,298 | $25 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 90 | $2,211 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 185 | $1,495 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 90 | $1,393 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $1,292 | $33 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,231 | $95 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 45 | $1,103 | $23 |
| Blood test, clotting time | 21 | $764 | $4 |
| Injection, aminophyllin, up to 250 mg | 102 | $677 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $668 | $23 |
| Infusion, normal saline solution, 250 cc | 135 | $520 | None |
2020: 23 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 610 | $139,864 | $207 |
| Return visit (30+ min) | 846 | $135,486 | $97 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 114 | $57,772 | $502 |
| Short return visit (20+ min) | 617 | $53,630 | $66 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 213 | $49,752 | $234 |
| Ultrasound of both sides of head and neck blood flow | 219 | $45,536 | $208 |
| New patient visit (45+ min) | 209 | $30,902 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,022 | $28,099 | $16 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 114 | $22,601 | $98 |
| Injection, regadenoson, 0.1 mg | 88 | $16,433 | None |
| Programming of dual lead pacemaker system | 110 | $11,783 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 93 | $6,181 | $64 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 114 | $3,452 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 103 | $2,777 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 103 | $2,525 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $2,057 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 45 | $1,847 | $27 |
| Blood test, clotting time | 25 | $1,060 | $4 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $1,015 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $893 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $665 | $22 |
| Injection, aminophyllin, up to 250 mg | 85 | $571 | None |
| Infusion, normal saline solution, 250 cc | 114 | $410 | None |
2019: 23 services
| Return visit (30+ min) | 875 | $136,590 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 547 | $117,956 | $203 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 128 | $66,193 | $501 |
| Short return visit (20+ min) | 707 | $64,868 | $66 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 186 | $42,671 | $228 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,154 | $35,388 | $15 |
| New patient visit (45+ min) | 229 | $32,668 | $143 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 128 | $25,216 | $96 |
| Injection, regadenoson, 0.1 mg | 101 | $18,347 | None |
| Programming of dual lead pacemaker system | 71 | $6,448 | $56 |
| Ultrasound of both sides of head and neck blood flow | 11 | $2,316 | $211 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 78 | $2,198 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 77 | $1,597 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 24 | $1,439 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 38 | $1,316 | $26 |
| External ekg recording for more than 48 hours up to 21 days | 48 | $1,208 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 146 | $1,184 | $8 |
| Blood test, clotting time | 32 | $1,113 | $4 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 48 | $1,093 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 43 | $1,053 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 34 | $1,048 | $26 |
| Injection, aminophyllin, up to 250 mg | 80 | $548 | None |
| Infusion, normal saline solution, 250 cc | 127 | $451 | None |
2018: 26 services
| Return visit (30+ min) | 774 | $117,480 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 504 | $103,199 | $193 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 117 | $55,929 | $478 |
| Short return visit (20+ min) | 608 | $51,106 | $60 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 164 | $34,795 | $210 |
| New patient visit (45+ min) | 236 | $32,117 | $136 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,022 | $30,551 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 118 | $21,219 | $90 |
| Injection, regadenoson, 0.1 mg | 92 | $16,315 | None |
| Programming of dual lead pacemaker system | 79 | $6,153 | $45 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,402 | $71 |
| New patient visit (60+ min) | 13 | $2,214 | $170 |
| Blood test, clotting time | 53 | $2,066 | $5 |
| Programming of multiple lead implantable defibrillator system | 15 | $1,982 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 68 | $1,777 | $26 |
| Measurement of heart blood flow and respiration | 52 | $1,399 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 68 | $1,287 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 149 | $1,164 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $1,141 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $986 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 27 | $946 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 37 | $941 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 37 | $833 | $22 |
| Injection, aminophyllin, up to 250 mg | 92 | $432 | None |
| Infusion, normal saline solution, 250 cc | 118 | $403 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $316 | $20 |
2017: 24 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 486 | $111,977 | $215 |
| Return visit (30+ min) | 670 | $104,972 | $89 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 117 | $56,852 | $486 |
| Short return visit (20+ min) | 506 | $43,631 | $61 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 129 | $32,357 | $251 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 860 | $27,369 | $15 |
| New patient visit (45+ min) | 189 | $26,623 | $141 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 117 | $21,488 | $92 |
| Injection, regadenoson, 0.1 mg | 101 | $17,525 | None |
| Programming of dual lead pacemaker system | 84 | $7,311 | $49 |
| Blood test, clotting time | 61 | $3,073 | $5 |
| Measurement of heart blood flow and respiration | 88 | $2,917 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 69 | $2,084 | $30 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $1,643 | $63 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,531 | $73 |
| External ekg recording for more than 48 hours up to 21 days | 51 | $1,400 | $26 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $1,368 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 70 | $1,349 | $19 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 51 | $1,281 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 126 | $994 | $7 |
| Injection, aminophyllin, up to 250 mg | 100 | $652 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $529 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $428 | $27 |
| Infusion, normal saline solution, 250 cc | 117 | $346 | None |
2016: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 323 | $72,666 | $214 |
| Return visit (30+ min) | 534 | $71,805 | $88 |
| Short return visit (20+ min) | 517 | $48,546 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 94 | $45,309 | $482 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 84 | $20,637 | $246 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 715 | $20,179 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 94 | $17,938 | $95 |
| New patient visit (45+ min) | 98 | $13,699 | $140 |
| Injection, regadenoson, 0.1 mg | 67 | $11,200 | None |
| Programming of dual lead pacemaker system | 60 | $4,559 | $48 |
| Blood test, clotting time | 69 | $4,300 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 83 | $2,494 | $30 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,097 | $72 |
| Measurement of heart blood flow and respiration | 58 | $1,845 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 83 | $1,596 | $19 |
| New patient visit (30+ min) | 17 | $1,548 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 106 | $854 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 15 | $536 | $24 |
| Injection, aminophyllin, up to 250 mg | 66 | $436 | None |
| Infusion, normal saline solution, 250 cc | 95 | $246 | None |
2015: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 395 | $90,171 | $219 |
| Return visit (30+ min) | 494 | $76,101 | $91 |
| Short return visit (20+ min) | 456 | $50,443 | $65 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 99 | $48,001 | $485 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 113 | $28,208 | $247 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 100 | $26,260 | $131 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 632 | $19,152 | $15 |
| Critical care, first 30-74 minutes | 19 | $17,181 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $16,030 | $92 |
| Injection, regadenoson, 0.1 mg | 83 | $13,745 | None |
| New patient visit (45+ min) | 84 | $11,829 | $141 |
| Blood test, clotting time | 72 | $4,800 | $5 |
| Programming of dual lead pacemaker system | 57 | $4,734 | $48 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $3,439 | $78 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 95 | $2,939 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 96 | $1,876 | $20 |
| Measurement of heart blood flow and respiration | 46 | $1,482 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,296 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 86 | $735 | $8 |
| Injection, aminophyllin, up to 250 mg | 82 | $376 | None |
| Infusion, normal saline solution, 250 cc | 101 | $227 | None |
2014: 22 services
| Return visit (30+ min) | 593 | $114,435 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 394 | $91,333 | $220 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 105 | $51,141 | $482 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 120 | $32,656 | $270 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 105 | $27,786 | $131 |
| Short return visit (20+ min) | 232 | $20,839 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 619 | $19,515 | $15 |
| New patient visit (45+ min) | 112 | $16,252 | $145 |
| Injection, regadenoson, 0.1 mg | 85 | $13,739 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 108 | $6,706 | $62 |
| Blood test, clotting time | 80 | $6,070 | $5 |
| Critical care, first 30-74 minutes | 18 | $6,038 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $5,687 | $90 |
| Programming of dual lead pacemaker system | 58 | $4,744 | $48 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,807 | $80 |
| New patient visit (60+ min) | 11 | $2,031 | $185 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $2,023 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,181 | $56 |
| Measurement of heart blood flow and respiration | 35 | $944 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $790 | $18 |
| Infusion, normal saline solution, 250 cc | 105 | $197 | None |
| Injection, aminophyllin, up to 250 mg | 72 | $148 | None |
2013: 20 services
| Return visit (30+ min) | 520 | $93,564 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 356 | $67,609 | $180 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 114 | $59,258 | $515 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 116 | $30,548 | $131 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 131 | $29,379 | $223 |
| Short return visit (20+ min) | 221 | $20,131 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 567 | $19,328 | $17 |
| New patient visit (45+ min) | 112 | $16,231 | $145 |
| Injection, regadenoson, 0.1 mg | 96 | $16,176 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 77 | $12,903 | $17 |
| Blood test, clotting time | 92 | $8,416 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 118 | $7,996 | $67 |
| Programming of dual lead pacemaker system | 51 | $3,992 | $48 |
| Programming of multiple lead implantable defibrillator system | 18 | $2,887 | $80 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,737 | $83 |
| Programming of single lead pacemaker system | 12 | $984 | $43 |
| Measurement of heart blood flow and respiration | 21 | $576 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $204 | $7 |
| Infusion, normal saline solution, 250 cc | 116 | $186 | None |
| Injection, aminophyllin, up to 250 mg | 60 | $46 | None |
Medicaid work
$203 in 2024
Medicaid paid $203 for 48 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 48 | $203 |
| 2024 | 48 | 1 | 24 | $203 |
| 2023 | 76 | 1 | 24 | $396 |
| 2022 | 78 | 1 | 22 | $281 |
| 2021 | 48 | 1 | 19 | $220 |
| 2020 | 12 | 1 | 12 | $64 |
| 2019 | 46 | 1 | 16 | $148 |
| 2018 | 14 | 1 | 14 | $67 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 76 | $396 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 78 | $281 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 48 | $220 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 12 | $64 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 46 | $148 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | $67 |
Drugs they prescribed that Part D paid
$3,267,134
Pharmacies billed $3,267,134 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
12,555 generic and fewer than 11 brand-name prescriptions · $3,267,134 in drug cost · 65 antibiotic prescriptions to 46 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 803 | $935,769 | $1,165 |
| Repatha Sureclick | 669 | $691,589 | $1,034 |
| Jardiance | 358 | $361,161 | $1,009 |
| Xarelto | 258 | $322,207 | $1,249 |
| Farxiga | 106 | $102,981 | $972 |
See all 99 drugs
| Eliquis | 803 | $935,769 | $1,165 |
| Repatha Sureclick | 669 | $691,589 | $1,034 |
| Jardiance | 358 | $361,161 | $1,009 |
| Xarelto | 258 | $322,207 | $1,249 |
| Farxiga | 106 | $102,981 | $972 |
| Entresto | 83 | $83,941 | $1,011 |
| Nebivolol | 660 | $51,552 | $78 |
| Vascepa | 74 | $43,237 | $584 |
| Edarbyclor | 70 | $35,074 | $501 |
| Nexlizet | 40 | $28,767 | $719 |
| Livalo | 32 | $22,490 | $703 |
| Ezetimibe | 732 | $21,554 | $29 |
| Praluent | 29 | $19,535 | $674 |
| Ozempic | 19 | $17,771 | $935 |
| Inpefa | 12 | $17,010 | $1,417 |
| Valsartan | 531 | $15,916 | $30 |
| Edarbi | 27 | $14,904 | $552 |
| Rosuvastatin | 1,125 | $14,820 | $13 |
| Amlodipine Besylate | 1,645 | $14,288 | $9 |
| Valsartan-Hydrochlorothiazide | 465 | $13,524 | $29 |
| Metoprolol | 937 | $13,491 | $14 |
| Atorvastatin | 1,225 | $12,925 | $11 |
| Pitavastatin | 36 | $12,018 | $334 |
| Diltiazem 24hr Er (Cd) | 291 | $10,743 | $37 |
| Synthroid | 89 | $10,135 | $114 |
| Multaq | 13 | $9,921 | $763 |
| Sotalol | 278 | $7,516 | $27 |
| Icosapent Ethyl | 22 | $7,243 | $329 |
| Norvasc | 11 | $6,170 | $561 |
| Dapagliflozin | 11 | $5,437 | $494 |
| Midodrine | 48 | $5,323 | $111 |
| Hydralazine | 283 | $5,316 | $19 |
| Tirosint | 12 | $4,627 | $386 |
| Pravastatin | 315 | $4,428 | $14 |
| Flecainide Acetate | 82 | $4,372 | $53 |
| Diltiazem 24hr Er (Xr) | 125 | $4,146 | $33 |
| Nifedipine Er | 93 | $3,957 | $43 |
| Bisoprolol | 163 | $3,942 | $24 |
| Losartan | 397 | $3,780 | $10 |
| Diltiazem 12hr Er | 17 | $3,640 | $214 |
| Levothyroxine | 137 | $3,486 | $25 |
| Potassium Chloride | 137 | $3,205 | $23 |
| Diltiazem 24hr Er (La) | 26 | $2,755 | $106 |
| Olmesartan-Hydrochlorothiazide | 44 | $2,610 | $59 |
| Ezetimibe-Simvastatin | 11 | $2,568 | $233 |
| Losartan-Hydrochlorothiazide | 131 | $2,342 | $18 |
| Furosemide | 338 | $2,289 | $7 |
| Bumetanide | 88 | $2,161 | $25 |
| Ranolazine Er | 20 | $2,156 | $108 |
| Metoprolol | 186 | $2,139 | $12 |
| Clopidogrel | 141 | $2,132 | $15 |
| Fenofibrate | 66 | $2,065 | $31 |
| Enoxaparin | 20 | $1,951 | $98 |
| Propranolol Hcl Er | 24 | $1,894 | $79 |
| Pindolol | 20 | $1,861 | $93 |
| Felodipine Er | 42 | $1,662 | $40 |
| Verapamil Er | 67 | $1,605 | $24 |
| Eplerenone | 15 | $1,532 | $102 |
| Hydrochlorothiazide | 216 | $1,450 | $7 |
| Verapamil Sr | 24 | $1,445 | $60 |
| Cartia Xt | 50 | $1,435 | $29 |
| Paxlovid | 12 | $1,429 | $119 |
| Dilt-Xr | 38 | $1,391 | $37 |
| Lisinopril | 155 | $1,305 | $8 |
| Labetalol | 37 | $1,212 | $33 |
| Niacin Er | 12 | $1,012 | $84 |
| Isosorbide Mononitrate Er | 48 | $998 | $21 |
| Amiodarone | 48 | $926 | $19 |
| Diltiazem | 51 | $907 | $18 |
| Olmesartan Medoxomil | 41 | $792 | $19 |
| Omega-3 Acid Ethyl Esters | 16 | $764 | $48 |
| Propranolol | 37 | $640 | $17 |
| Diltiazem 24hr Er | 27 | $590 | $22 |
| Fenofibric Acid | 12 | $586 | $49 |
| Simvastatin | 74 | $542 | $7 |
| Atenolol | 90 | $538 | $6 |
| Digoxin | 12 | $485 | $40 |
| Sotalol Af | 13 | $478 | $37 |
| Fludrocortisone Acetate | 15 | $430 | $29 |
| Spironolactone | 63 | $411 | $7 |
| Pantoprazole | 30 | $397 | $13 |
| Warfarin | 68 | $373 | $5 |
| Ramipril | 19 | $318 | $17 |
| Lisinopril-Hydrochlorothiazide | 27 | $316 | $12 |
| Clonidine | 19 | $291 | $15 |
| Carvedilol | 48 | $281 | $6 |
| Nitroglycerin | 16 | $280 | $17 |
| Klor-Con 10 | 13 | $272 | $21 |
| Irbesartan | 23 | $257 | $11 |
| Vitamin D2 | 21 | $234 | $11 |
| Benazepril | 15 | $225 | $15 |
| Omeprazole | 21 | $198 | $9 |
| Azithromycin | 24 | $144 | $6 |
| Allopurinol | 13 | $118 | $9 |
| Amoxicillin | 25 | $93 | $4 |
| Famotidine | 11 | $62 | $6 |
| Sertraline | 13 | $58 | $4 |
| Metformin | 18 | $24 | $1 |
| Meclizine | 14 | $16 | $1 |
Year by year
| 2024 | 15,579 | 1,811 | None | None | $3,267,134 |
| 2023 | 13,771 | 1,620 | None | 20% | $2,908,736 |
| 2022 | 12,121 | 1,455 | 0% (0) | None | $2,284,090 |
| 2021 | 11,150 | 1,338 | None | None | $2,010,151 |
| 2020 | 10,446 | 1,205 | None | None | $1,743,602 |
| 2019 | 9,308 | 1,074 | None | 26% | $1,372,358 |
| 2018 | 8,810 | 943 | None | None | $1,141,622 |
| 2017 | 8,165 | 769 | 0% (18) | 30% | $882,697 |
| 2016 | 6,920 | 655 | 1% (46) | 32% | $735,340 |
| 2015 | 6,446 | 593 | None | 37% | $637,594 |
| 2014 | 6,113 | 538 | None | None | $527,366 |
| 2013 | 5,412 | 441 | None | 37% | $427,619 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 90 drugs
| Eliquis | 802 | $923,397 | $1,151 |
| Repatha Sureclick | 694 | $686,763 | $990 |
| Xarelto | 340 | $418,172 | $1,230 |
| Entresto | 69 | $88,220 | $1,279 |
| Jardiance | 69 | $82,658 | $1,198 |
| Nebivolol | 564 | $63,754 | $113 |
| Livalo | 61 | $47,103 | $772 |
| Praluent | 56 | $45,480 | $812 |
| Repatha Pushtronex | 49 | $45,083 | $920 |
| Edarbyclor | 68 | $36,260 | $533 |
| Icosapent Ethyl | 64 | $29,881 | $467 |
| Vascepa | 32 | $27,883 | $871 |
| Farxiga | 23 | $26,243 | $1,141 |
| Ezetimibe | 540 | $25,773 | $48 |
| Valsartan-Hydrochlorothiazide | 404 | $19,075 | $47 |
| Valsartan | 374 | $18,927 | $51 |
| Edarbi | 30 | $16,471 | $549 |
| Diltiazem 24hr Er (Cd) | 319 | $16,411 | $51 |
| Metoprolol | 825 | $16,263 | $20 |
| Rosuvastatin | 747 | $15,870 | $21 |
| Atorvastatin | 1,217 | $15,326 | $13 |
| Amlodipine Besylate | 1,337 | $13,835 | $10 |
| Brilinta | 13 | $10,595 | $815 |
| Synthroid | 90 | $10,075 | $112 |
| Nexlizet | 13 | $8,947 | $688 |
| Sotalol | 281 | $7,957 | $28 |
| Nifedipine Er | 123 | $7,573 | $62 |
| Diltiazem 24hr Er (Xr) | 120 | $6,152 | $51 |
| Flecainide Acetate | 95 | $5,930 | $62 |
| Pravastatin | 325 | $5,816 | $18 |
| Bisoprolol | 149 | $5,750 | $39 |
| Norvasc | 14 | $5,719 | $409 |
| Losartan | 402 | $5,640 | $14 |
| Potassium Chloride | 144 | $5,024 | $35 |
| Nitroglycerin | 29 | $4,996 | $172 |
| Diltiazem 12hr Er | 23 | $4,757 | $207 |
| Midodrine | 35 | $4,549 | $130 |
| Ranolazine Er | 32 | $3,919 | $122 |
| Ezetimibe-Simvastatin | 15 | $3,847 | $256 |
| Hydralazine | 152 | $3,732 | $25 |
| Losartan-Hydrochlorothiazide | 123 | $3,516 | $29 |
| Levothyroxine | 128 | $3,407 | $27 |
| Olmesartan-Hydrochlorothiazide | 47 | $2,937 | $62 |
| Clopidogrel | 148 | $2,736 | $18 |
| Furosemide | 338 | $2,406 | $7 |
| Metoprolol | 185 | $2,378 | $13 |
| Felodipine Er | 41 | $2,297 | $56 |
| Olmesartan Medoxomil | 56 | $2,198 | $39 |
| Bumetanide | 53 | $2,174 | $41 |
| Verapamil Er | 60 | $2,083 | $35 |
| Hydrochlorothiazide | 209 | $2,072 | $10 |
| Cartia Xt | 59 | $1,985 | $34 |
| Eplerenone | 21 | $1,868 | $89 |
| Isosorbide Mononitrate Er | 60 | $1,809 | $30 |
| Omega-3 Acid Ethyl Esters | 16 | $1,800 | $113 |
| Fenofibrate | 58 | $1,481 | $26 |
| Propranolol Hcl Er | 16 | $1,478 | $92 |
| Amiodarone | 78 | $1,321 | $17 |
| Pindolol | 16 | $1,305 | $82 |
| Diltiazem 24hr Er | 40 | $1,285 | $32 |
| Verapamil Sr | 14 | $1,212 | $87 |
| Simvastatin | 99 | $1,146 | $12 |
| Warfarin | 64 | $1,102 | $17 |
| Carvedilol | 57 | $1,091 | $19 |
| Dilt-Xr | 19 | $1,089 | $57 |
| Diltiazem | 52 | $1,018 | $20 |
| Labetalol | 31 | $864 | $28 |
| Lisinopril | 98 | $851 | $9 |
| Digoxin | 17 | $818 | $48 |
| Spironolactone | 47 | $779 | $17 |
| Atenolol | 80 | $651 | $8 |
| Sotalol Af | 14 | $651 | $46 |
| Pantoprazole | 31 | $623 | $20 |
| Amlodipine Besylate-Benazepril | 11 | $591 | $54 |
| Propranolol | 31 | $507 | $16 |
| Fludrocortisone Acetate | 16 | $495 | $31 |
| Clonidine | 25 | $488 | $20 |
| Chlorthalidone | 11 | $421 | $38 |
| Omeprazole | 21 | $401 | $19 |
| Tamsulosin | 28 | $392 | $14 |
| Irbesartan | 28 | $391 | $14 |
| Lisinopril-Hydrochlorothiazide | 30 | $331 | $11 |
| Benazepril | 16 | $328 | $20 |
| Ramipril | 19 | $321 | $17 |
| Famotidine | 14 | $254 | $18 |
| Triamterene-Hydrochlorothiazid | 13 | $226 | $17 |
| Allopurinol | 12 | $159 | $13 |
| Paxlovid (Eua) | 14 | $150 | $11 |
| Azithromycin | 18 | $137 | $8 |
| Folic Acid | 15 | $23 | $2 |
2022: 93 drugs
| Eliquis | 656 | $679,484 | $1,036 |
| Repatha Sureclick | 528 | $427,932 | $810 |
| Xarelto | 314 | $372,908 | $1,188 |
| Entresto | 87 | $108,632 | $1,249 |
| Repatha Pushtronex | 83 | $57,657 | $695 |
| Praluent | 77 | $53,487 | $695 |
| Nebivolol | 439 | $50,185 | $114 |
| Livalo | 53 | $45,214 | $853 |
| Vascepa | 47 | $35,011 | $745 |
| Edarbyclor | 75 | $31,466 | $420 |
| Ezetimibe | 442 | $31,272 | $71 |
| Brilinta | 27 | $23,288 | $863 |
| Diltiazem 24hr Er (Cd) | 445 | $19,145 | $43 |
| Bystolic | 54 | $18,059 | $334 |
| Icosapent Ethyl | 37 | $16,593 | $448 |
| Valsartan-Hydrochlorothiazide | 351 | $16,382 | $47 |
| Atorvastatin | 1,157 | $14,981 | $13 |
| Valsartan | 259 | $14,099 | $54 |
| Metoprolol | 707 | $13,329 | $19 |
| Edarbi | 31 | $12,540 | $405 |
| Rosuvastatin | 422 | $12,425 | $29 |
| Synthroid | 101 | $11,112 | $110 |
| Amlodipine Besylate | 1,035 | $9,154 | $9 |
| Nifedipine Er | 142 | $9,131 | $64 |
| Bisoprolol | 159 | $7,170 | $45 |
| Flecainide Acetate | 97 | $6,389 | $66 |
| Olmesartan-Hydrochlorothiazide | 60 | $6,337 | $106 |
| Diltiazem 12hr Er | 32 | $5,982 | $187 |
| Sotalol | 202 | $5,485 | $27 |
| Eplerenone | 32 | $5,417 | $169 |
| Pravastatin | 291 | $5,263 | $18 |
| Nitroglycerin | 17 | $5,180 | $305 |
| Potassium Chloride | 123 | $4,988 | $41 |
| Losartan | 361 | $4,847 | $13 |
| Clonidine | 11 | $4,391 | $399 |
| Ranolazine Er | 40 | $4,066 | $102 |
| Bumetanide | 61 | $4,047 | $66 |
| Hydralazine | 131 | $3,990 | $30 |
| Fenofibrate | 46 | $3,606 | $78 |
| Losartan-Hydrochlorothiazide | 106 | $3,391 | $32 |
| Midodrine | 33 | $3,082 | $93 |
| Omega-3 Acid Ethyl Esters | 21 | $2,873 | $137 |
| Clopidogrel | 142 | $2,800 | $20 |
| Ezetimibe-Simvastatin | 12 | $2,799 | $233 |
| Olmesartan Medoxomil | 65 | $2,687 | $41 |
| Verapamil Er | 66 | $2,582 | $39 |
| Felodipine Er | 37 | $2,445 | $66 |
| Levothyroxine | 116 | $2,441 | $21 |
| Furosemide | 293 | $2,248 | $8 |
| Verapamil Sr | 28 | $2,203 | $79 |
| Hydrochlorothiazide | 239 | $2,137 | $9 |
| Diltiazem 24hr Er (Xr) | 42 | $2,128 | $51 |
| Labetalol | 25 | $1,871 | $75 |
| Warfarin | 87 | $1,804 | $21 |
| Isosorbide Mononitrate Er | 50 | $1,735 | $35 |
| Metoprolol | 183 | $1,699 | $9 |
| Niacin Er | 14 | $1,612 | $115 |
| Propranolol | 54 | $1,492 | $28 |
| Dilt-Xr | 27 | $1,467 | $54 |
| Amiodarone | 63 | $1,347 | $21 |
| Diltiazem | 37 | $1,319 | $36 |
| Isosorbide Dinitrate | 11 | $1,268 | $115 |
| Diltiazem 24hr Er | 33 | $1,225 | $37 |
| Propafenone | 13 | $1,197 | $92 |
| Propranolol Hcl Er | 14 | $1,112 | $79 |
| Lisinopril | 107 | $1,026 | $10 |
| Carvedilol | 63 | $993 | $16 |
| Digoxin | 21 | $990 | $47 |
| Simvastatin | 121 | $984 | $8 |
| Fenofibric Acid | 15 | $972 | $65 |
| Fludrocortisone Acetate | 19 | $831 | $44 |
| Tadalafil | 12 | $740 | $62 |
| Amlodipine Besylate-Benazepril | 17 | $733 | $43 |
| Chlorthalidone | 16 | $732 | $46 |
| Atenolol | 83 | $714 | $9 |
| Spironolactone | 43 | $635 | $15 |
| Pantoprazole | 38 | $587 | $15 |
| Levoxyl | 24 | $562 | $23 |
| Irbesartan | 20 | $486 | $24 |
| Cartia Xt | 14 | $401 | $29 |
| Famotidine | 22 | $346 | $16 |
| Lisinopril-Hydrochlorothiazide | 29 | $345 | $12 |
| Omeprazole | 18 | $315 | $17 |
| Benazepril | 16 | $308 | $19 |
| Clonidine | 26 | $304 | $12 |
| Verapamil | 11 | $272 | $25 |
| Tamsulosin | 20 | $269 | $13 |
| Ramipril | 18 | $209 | $12 |
| Lovastatin | 11 | $207 | $19 |
| Allopurinol | 12 | $177 | $15 |
| Azithromycin | 19 | $162 | $9 |
| Triamterene-Hydrochlorothiazid | 14 | $151 | $11 |
| Amoxicillin | 12 | $38 | $3 |
2021: 88 drugs
| Eliquis | 623 | $626,807 | $1,006 |
| Xarelto | 268 | $306,879 | $1,145 |
| Repatha Sureclick | 441 | $298,528 | $677 |
| Bystolic | 356 | $150,201 | $422 |
| Entresto | 31 | $49,283 | $1,590 |
| Vascepa | 84 | $49,235 | $586 |
| Livalo | 54 | $41,721 | $773 |
| Edarbyclor | 89 | $40,248 | $452 |
| Praluent | 61 | $31,952 | $524 |
| Ezetimibe | 392 | $26,280 | $67 |
| Repatha Pushtronex | 37 | $26,201 | $708 |
| Diltiazem 24hr Er (Cd) | 421 | $22,189 | $53 |
| Atorvastatin | 1,059 | $14,801 | $14 |
| Edarbi | 37 | $14,247 | $385 |
| Synthroid | 133 | $14,121 | $106 |
| Metoprolol | 660 | $13,566 | $21 |
| Nebivolol | 57 | $13,383 | $235 |
| Nifedipine Er | 220 | $13,106 | $60 |
| Valsartan-Hydrochlorothiazide | 253 | $13,019 | $51 |
| Bisoprolol | 179 | $10,556 | $59 |
| Rosuvastatin | 316 | $9,035 | $29 |
| Flecainide Acetate | 102 | $8,979 | $88 |
| Valsartan | 156 | $8,942 | $57 |
| Diltiazem 12hr Er | 27 | $7,758 | $287 |
| Amlodipine Besylate | 838 | $7,262 | $9 |
| Ranolazine Er | 55 | $6,142 | $112 |
| Losartan | 372 | $5,673 | $15 |
| Sotalol | 218 | $5,591 | $26 |
| Potassium Chloride | 110 | $4,254 | $39 |
| Olmesartan-Hydrochlorothiazide | 51 | $4,126 | $81 |
| Pravastatin | 224 | $3,984 | $18 |
| Losartan-Hydrochlorothiazide | 130 | $3,784 | $29 |
| Omega-3 Acid Ethyl Esters | 23 | $3,685 | $160 |
| Midodrine | 42 | $3,684 | $88 |
| Bumetanide | 55 | $3,470 | $63 |
| Eplerenone | 20 | $3,252 | $163 |
| Clopidogrel | 168 | $3,199 | $19 |
| Nitroglycerin | 18 | $3,130 | $174 |
| Dilt-Xr | 37 | $3,048 | $82 |
| Verapamil Er | 85 | $3,016 | $35 |
| Cartia Xt | 51 | $2,929 | $57 |
| Olmesartan Medoxomil | 61 | $2,906 | $48 |
| Levothyroxine | 138 | $2,665 | $19 |
| Ezetimibe-Simvastatin | 13 | $2,663 | $205 |
| Labetalol | 28 | $2,619 | $94 |
| Propranolol Hcl Er | 32 | $2,600 | $81 |
| Tirosint | 11 | $2,373 | $216 |
| Fenofibric Acid | 12 | $2,335 | $195 |
| Hydrochlorothiazide | 266 | $2,256 | $8 |
| Fenofibrate | 22 | $2,159 | $98 |
| Furosemide | 305 | $2,111 | $7 |
| Felodipine Er | 27 | $2,030 | $75 |
| Verapamil Sr | 22 | $1,901 | $86 |
| Warfarin | 85 | $1,635 | $19 |
| Metoprolol | 158 | $1,626 | $10 |
| Hydralazine | 54 | $1,574 | $29 |
| Diltiazem 24hr Er | 20 | $1,390 | $70 |
| Isosorbide Mononitrate Er | 52 | $1,390 | $27 |
| Lisinopril | 119 | $1,175 | $10 |
| Simvastatin | 109 | $1,138 | $10 |
| Propafenone | 14 | $1,125 | $80 |
| Chlorthalidone | 28 | $1,120 | $40 |
| Carvedilol | 76 | $1,099 | $14 |
| Propranolol | 31 | $972 | $31 |
| Levoxyl | 30 | $936 | $31 |
| Amiodarone | 36 | $929 | $26 |
| Atenolol | 104 | $844 | $8 |
| Pantoprazole | 39 | $763 | $20 |
| Amlodipine Besylate-Benazepril | 19 | $710 | $37 |
| Spironolactone | 58 | $598 | $10 |
| Doxazosin Mesylate | 18 | $497 | $28 |
| Famotidine | 24 | $375 | $16 |
| Benazepril | 19 | $368 | $19 |
| Diltiazem | 11 | $362 | $33 |
| Verapamil | 14 | $348 | $25 |
| Tadalafil | 12 | $339 | $28 |
| Digoxin | 15 | $329 | $22 |
| Fludrocortisone Acetate | 11 | $328 | $30 |
| Triamterene-Hydrochlorothiazid | 27 | $322 | $12 |
| Lisinopril-Hydrochlorothiazide | 27 | $301 | $11 |
| Clonidine | 22 | $255 | $12 |
| Allopurinol | 16 | $252 | $16 |
| Lovastatin | 14 | $213 | $15 |
| Irbesartan | 11 | $205 | $19 |
| Ramipril | 19 | $183 | $10 |
| Quinapril | 13 | $161 | $12 |
| Azithromycin | 13 | $106 | $8 |
| Amoxicillin | 20 | $81 | $4 |
2020: 90 drugs
| Eliquis | 517 | $478,756 | $926 |
| Xarelto | 236 | $259,592 | $1,100 |
| Repatha Sureclick | 407 | $235,331 | $578 |
| Bystolic | 460 | $182,001 | $396 |
| Entresto | 38 | $53,830 | $1,417 |
| Livalo | 53 | $41,248 | $778 |
| Vascepa | 73 | $37,331 | $511 |
| Edarbyclor | 77 | $35,970 | $467 |
| Ezetimibe | 311 | $21,713 | $70 |
| Diltiazem 24hr Er (Cd) | 353 | $19,194 | $54 |
| Atorvastatin | 1,008 | $16,096 | $16 |
| Ranolazine Er | 76 | $15,619 | $206 |
| Pradaxa | 11 | $15,109 | $1,374 |
| Edarbi | 53 | $14,809 | $279 |
| Synthroid | 147 | $13,992 | $95 |
| Metoprolol | 550 | $13,798 | $25 |
| Flecainide Acetate | 106 | $13,508 | $127 |
| Valsartan-Hydrochlorothiazide | 228 | $12,714 | $56 |
| Nifedipine Er | 227 | $12,564 | $55 |
| Rosuvastatin | 284 | $11,787 | $42 |
| Repatha | 12 | $9,295 | $775 |
| Valsartan | 144 | $8,760 | $61 |
| Diltiazem 12hr Er | 32 | $8,289 | $259 |
| Sotalol | 223 | $8,112 | $36 |
| Repatha Pushtronex | 12 | $7,770 | $648 |
| Potassium Chloride | 134 | $7,383 | $55 |
| Praluent | 11 | $6,920 | $629 |
| Bisoprolol | 122 | $6,716 | $55 |
| Losartan-Hydrochlorothiazide | 146 | $6,582 | $45 |
| Tirosint | 24 | $6,440 | $268 |
| Losartan | 391 | $6,424 | $16 |
| Omega-3 Acid Ethyl Esters | 37 | $6,320 | $171 |
| Amlodipine Besylate | 681 | $5,857 | $9 |
| Ezetimibe-Simvastatin | 13 | $4,894 | $376 |
| Propafenone Hcl Er | 13 | $4,324 | $333 |
| Olmesartan-Hydrochlorothiazide | 67 | $4,247 | $63 |
| Bumetanide | 84 | $3,893 | $46 |
| Levothyroxine | 156 | $3,876 | $25 |
| Cartia Xt | 83 | $3,870 | $47 |
| Clopidogrel | 187 | $3,774 | $20 |
| Olmesartan Medoxomil | 67 | $3,702 | $55 |
| Nitroglycerin | 24 | $3,526 | $147 |
| Pravastatin | 160 | $3,388 | $21 |
| Olmesartan-Amlodipine-Hctz | 12 | $3,309 | $276 |
| Colesevelam | 17 | $3,088 | $182 |
| Verapamil Er | 79 | $2,763 | $35 |
| Hydrochlorothiazide | 260 | $2,681 | $10 |
| Diltiazem 24hr Er | 45 | $2,652 | $59 |
| Propranolol Hcl Er | 23 | $2,313 | $101 |
| Dilt-Xr | 38 | $2,282 | $60 |
| Warfarin | 94 | $2,235 | $24 |
| Verapamil Sr | 27 | $2,140 | $79 |
| Enoxaparin | 19 | $2,102 | $111 |
| Furosemide | 294 | $2,066 | $7 |
| Midodrine | 22 | $1,629 | $74 |
| Isosorbide Mononitrate Er | 49 | $1,499 | $31 |
| Metoprolol | 154 | $1,404 | $9 |
| Eplerenone | 12 | $1,353 | $113 |
| Fenofibrate | 11 | $1,351 | $123 |
| Amiodarone | 50 | $1,317 | $26 |
| Labetalol | 22 | $1,237 | $56 |
| Hydralazine | 37 | $1,160 | $31 |
| Levoxyl | 29 | $1,155 | $40 |
| Chlorthalidone | 26 | $1,138 | $44 |
| Lisinopril | 115 | $1,113 | $10 |
| Atenolol | 117 | $996 | $9 |
| Propranolol | 26 | $944 | $36 |
| Carvedilol | 66 | $941 | $14 |
| Felodipine Er | 12 | $896 | $75 |
| Simvastatin | 95 | $847 | $9 |
| Fludrocortisone Acetate | 15 | $767 | $51 |
| Pantoprazole | 41 | $746 | $18 |
| Propafenone | 12 | $674 | $56 |
| Spironolactone | 54 | $632 | $12 |
| Enalapril Maleate | 11 | $560 | $51 |
| Doxazosin Mesylate | 13 | $502 | $39 |
| Digoxin | 21 | $428 | $20 |
| Bisoprolol-Hydrochlorothiazide | 12 | $373 | $31 |
| Triamterene-Hydrochlorothiazid | 35 | $359 | $10 |
| Tadalafil | 13 | $337 | $26 |
| Allopurinol | 17 | $337 | $20 |
| Omeprazole | 14 | $296 | $21 |
| Clonidine | 21 | $263 | $13 |
| Benazepril | 16 | $229 | $14 |
| Lisinopril-Hydrochlorothiazide | 23 | $215 | $9 |
| Famotidine | 19 | $190 | $10 |
| Ramipril | 13 | $185 | $14 |
| Lovastatin | 13 | $181 | $14 |
| Azithromycin | 11 | $113 | $10 |
| Alprazolam | 11 | $37 | $3 |
2019: 83 drugs
| Eliquis | 372 | $336,254 | $904 |
| Xarelto | 189 | $173,954 | $920 |
| Bystolic | 483 | $166,227 | $344 |
| Repatha Sureclick | 192 | $134,232 | $699 |
| Entresto | 40 | $46,549 | $1,164 |
| Edarbyclor | 132 | $43,032 | $326 |
| Livalo | 53 | $38,537 | $727 |
| Vascepa | 65 | $35,813 | $551 |
| Diltiazem 24hr Er (Cd) | 364 | $20,129 | $55 |
| Edarbi | 67 | $18,761 | $280 |
| Ezetimibe | 221 | $17,404 | $79 |
| Synthroid | 200 | $17,054 | $85 |
| Ranolazine Er | 48 | $16,358 | $341 |
| Pradaxa | 17 | $15,978 | $940 |
| Atorvastatin | 839 | $14,629 | $17 |
| Nifedipine Er | 221 | $13,852 | $63 |
| Rosuvastatin | 255 | $13,209 | $52 |
| Metoprolol | 420 | $12,288 | $29 |
| Ranexa | 17 | $10,183 | $599 |
| Valsartan-Hydrochlorothiazide | 223 | $10,146 | $45 |
| Flecainide Acetate | 112 | $9,593 | $86 |
| Sotalol | 207 | $8,319 | $40 |
| Potassium Chloride | 116 | $8,250 | $71 |
| Omega-3 Acid Ethyl Esters | 39 | $7,236 | $186 |
| Valsartan | 123 | $6,067 | $49 |
| Amlodipine Besylate | 571 | $6,013 | $11 |
| Diltiazem 12hr Er | 25 | $5,880 | $235 |
| Cartia Xt | 134 | $5,754 | $43 |
| Tirosint | 24 | $5,499 | $229 |
| Ezetimibe-Simvastatin | 20 | $5,497 | $275 |
| Nitroglycerin | 18 | $5,362 | $298 |
| Olmesartan-Hydrochlorothiazide | 77 | $5,024 | $65 |
| Losartan | 333 | $4,697 | $14 |
| Colesevelam | 19 | $4,333 | $228 |
| Propafenone Hcl Er | 16 | $4,058 | $254 |
| Olmesartan-Amlodipine-Hctz | 15 | $3,815 | $254 |
| Clopidogrel | 169 | $3,758 | $22 |
| Bumetanide | 81 | $3,714 | $46 |
| Tadalafil | 16 | $3,549 | $222 |
| Olmesartan Medoxomil | 56 | $3,367 | $60 |
| Levothyroxine | 142 | $3,273 | $23 |
| Propranolol Hcl Er | 25 | $2,902 | $116 |
| Verapamil Er | 110 | $2,840 | $26 |
| Pravastatin | 126 | $2,763 | $22 |
| Fenofibric Acid | 20 | $2,761 | $138 |
| Hydrochlorothiazide | 252 | $2,568 | $10 |
| Warfarin | 118 | $2,453 | $21 |
| Losartan-Hydrochlorothiazide | 174 | $2,406 | $14 |
| Midodrine | 26 | $2,359 | $91 |
| Isosorbide Mononitrate Er | 62 | $2,331 | $38 |
| Verapamil Sr | 27 | $1,996 | $74 |
| Furosemide | 253 | $1,848 | $7 |
| Levoxyl | 40 | $1,764 | $44 |
| Dilt-Xr | 28 | $1,746 | $62 |
| Pindolol | 12 | $1,547 | $129 |
| Diltiazem 24hr Er | 27 | $1,409 | $52 |
| Metoprolol | 118 | $1,337 | $11 |
| Bisoprolol | 38 | $1,334 | $35 |
| Carvedilol | 86 | $1,318 | $15 |
| Niacin Er | 12 | $1,234 | $103 |
| Chlorthalidone | 21 | $1,221 | $58 |
| Amiodarone | 47 | $1,049 | $22 |
| Atenolol | 113 | $1,005 | $9 |
| Pantoprazole | 57 | $995 | $17 |
| Simvastatin | 98 | $969 | $10 |
| Propranolol | 27 | $895 | $33 |
| Lisinopril | 89 | $834 | $9 |
| Hydralazine | 14 | $786 | $56 |
| Spironolactone | 45 | $706 | $16 |
| Propafenone | 15 | $608 | $41 |
| Digoxin | 12 | $556 | $46 |
| Triamterene-Hydrochlorothiazid | 39 | $389 | $10 |
| Omeprazole | 15 | $373 | $25 |
| Verapamil | 13 | $317 | $24 |
| Lisinopril-Hydrochlorothiazide | 18 | $294 | $16 |
| Ramipril | 13 | $237 | $18 |
| Clonidine | 17 | $218 | $13 |
| Diltiazem | 16 | $213 | $13 |
| Bisoprolol-Hydrochlorothiazide | 11 | $187 | $17 |
| Benazepril | 12 | $148 | $12 |
| Tamsulosin | 12 | $143 | $12 |
| Lovastatin | 13 | $130 | $10 |
| Alprazolam | 14 | $74 | $5 |
2018: 80 drugs
| Eliquis | 315 | $267,550 | $849 |
| Bystolic | 540 | $155,524 | $288 |
| Xarelto | 144 | $101,773 | $707 |
| Repatha Sureclick | 68 | $74,172 | $1,091 |
| Ranexa | 86 | $53,491 | $622 |
| Entresto | 42 | $41,932 | $998 |
| Edarbyclor | 160 | $38,455 | $240 |
| Ezetimibe | 208 | $28,859 | $139 |
| Edarbi | 107 | $27,037 | $253 |
| Vascepa | 45 | $22,129 | $492 |
| Synthroid | 235 | $18,615 | $79 |
| Livalo | 30 | $17,627 | $588 |
| Pradaxa | 17 | $16,665 | $980 |
| Atorvastatin | 676 | $12,804 | $19 |
| Omega-3 Acid Ethyl Esters | 58 | $12,276 | $212 |
| Metoprolol | 380 | $11,884 | $31 |
| Rosuvastatin | 285 | $10,896 | $38 |
| Flecainide Acetate | 97 | $9,532 | $98 |
| Cartia Xt | 223 | $9,272 | $42 |
| Diltiazem 24hr Er (Cd) | 242 | $8,914 | $37 |
| Nifedipine Er | 158 | $8,813 | $56 |
| Potassium Chloride | 126 | $8,091 | $64 |
| Tirosint | 35 | $8,046 | $230 |
| Cialis | 13 | $7,671 | $590 |
| Olmesartan-Amlodipine-Hctz | 32 | $7,444 | $233 |
| Sotalol | 188 | $5,932 | $32 |
| Savaysa | 16 | $5,533 | $346 |
| Welchol | 14 | $5,366 | $383 |
| Verapamil Er | 154 | $5,207 | $34 |
| Propafenone Hcl Er | 14 | $5,118 | $366 |
| Amlodipine Besylate | 514 | $4,579 | $9 |
| Valsartan-Hydrochlorothiazide | 103 | $4,211 | $41 |
| Valsartan | 90 | $3,862 | $43 |
| Bumetanide | 71 | $3,808 | $54 |
| Olmesartan Medoxomil | 51 | $3,458 | $68 |
| Clopidogrel | 194 | $3,430 | $18 |
| Olmesartan-Hydrochlorothiazide | 54 | $3,209 | $59 |
| Losartan | 279 | $3,053 | $11 |
| Pravastatin | 136 | $2,928 | $22 |
| Fenofibric Acid | 18 | $2,835 | $158 |
| Levothyroxine | 163 | $2,823 | $17 |
| Warfarin | 125 | $2,810 | $22 |
| Propranolol Hcl Er | 23 | $2,687 | $117 |
| Isosorbide Mononitrate Er | 64 | $2,621 | $41 |
| Verapamil Er Pm | 20 | $2,534 | $127 |
| Hydrochlorothiazide | 225 | $2,396 | $11 |
| Levoxyl | 72 | $2,049 | $28 |
| Losartan-Hydrochlorothiazide | 152 | $1,863 | $12 |
| Metoprolol | 147 | $1,656 | $11 |
| Enoxaparin | 20 | $1,569 | $78 |
| Midodrine | 18 | $1,462 | $81 |
| Furosemide | 248 | $1,446 | $6 |
| Pindolol | 17 | $1,234 | $73 |
| Niacin Er | 14 | $1,214 | $87 |
| Atenolol | 118 | $1,154 | $10 |
| Prazosin | 14 | $1,117 | $80 |
| Telmisartan | 13 | $1,069 | $82 |
| Amiodarone | 52 | $1,007 | $19 |
| Carvedilol | 102 | $1,007 | $10 |
| Simvastatin | 98 | $1,002 | $10 |
| Dilt-Xr | 18 | $979 | $54 |
| Lisinopril | 88 | $840 | $10 |
| Verapamil Sr | 12 | $823 | $69 |
| Hydralazine | 26 | $815 | $31 |
| Chlorthalidone | 16 | $813 | $51 |
| Pantoprazole | 61 | $786 | $13 |
| Diltiazem 24hr Er | 13 | $743 | $57 |
| Propranolol | 21 | $693 | $33 |
| Klor-Con Sprinkle | 15 | $672 | $45 |
| Spironolactone | 58 | $573 | $10 |
| Omeprazole | 22 | $481 | $22 |
| Triamterene-Hydrochlorothiazid | 39 | $473 | $12 |
| Nitroglycerin | 20 | $456 | $23 |
| Clonidine | 28 | $193 | $7 |
| Lisinopril-Hydrochlorothiazide | 20 | $153 | $8 |
| Lovastatin | 12 | $123 | $10 |
| Benazepril | 14 | $121 | $9 |
| Ranitidine | 19 | $116 | $6 |
| Verapamil | 12 | $109 | $9 |
| Amoxicillin | 14 | $53 | $4 |
2017: 90 drugs
| Eliquis | 303 | $175,573 | $579 |
| Bystolic | 496 | $118,442 | $239 |
| Xarelto | 116 | $60,598 | $522 |
| Ranexa | 67 | $44,153 | $659 |
| Zetia | 46 | $37,964 | $825 |
| Entresto | 48 | $27,355 | $570 |
| Ezetimibe | 115 | $20,560 | $179 |
| Vascepa | 46 | $18,807 | $409 |
| Pradaxa | 19 | $16,430 | $865 |
| Crestor | 30 | $15,926 | $531 |
| Synthroid | 221 | $15,433 | $70 |
| Rosuvastatin | 292 | $14,806 | $51 |
| Repatha Sureclick | 12 | $13,579 | $1,132 |
| Edarbyclor | 70 | $13,297 | $190 |
| Effient | 20 | $12,379 | $619 |
| Omega-3 Acid Ethyl Esters | 48 | $11,513 | $240 |
| Metoprolol | 407 | $10,711 | $26 |
| Welchol | 33 | $10,334 | $313 |
| Atorvastatin | 548 | $9,767 | $18 |
| Edarbi | 41 | $9,064 | $221 |
| Cialis | 13 | $7,949 | $611 |
| Flecainide Acetate | 111 | $7,459 | $67 |
| Tirosint | 43 | $7,292 | $170 |
| Olmesartan-Amlodipine-Hctz | 19 | $7,291 | $384 |
| Olmesartan-Hydrochlorothiazide | 34 | $7,206 | $212 |
| Valsartan | 160 | $6,195 | $39 |
| Nifedipine Er | 111 | $6,103 | $55 |
| Livalo | 11 | $5,912 | $537 |
| Cartia Xt | 164 | $5,485 | $33 |
| Sotalol | 240 | $5,383 | $22 |
| Fenofibric Acid | 30 | $5,327 | $178 |
| Olmesartan Medoxomil | 18 | $4,965 | $276 |
| Potassium Chloride | 105 | $4,789 | $46 |
| Diltiazem 24hr Er | 196 | $4,310 | $22 |
| Propafenone Hcl Er | 14 | $4,216 | $301 |
| Tribenzor | 12 | $3,741 | $312 |
| Warfarin | 196 | $3,551 | $18 |
| Levothyroxine | 172 | $3,349 | $19 |
| Bumetanide | 82 | $3,159 | $39 |
| Amlodipine Besylate | 389 | $3,058 | $8 |
| Clopidogrel | 184 | $2,837 | $15 |
| Verapamil Er | 133 | $2,756 | $21 |
| Hydrochlorothiazide | 249 | $2,608 | $10 |
| Valsartan-Hydrochlorothiazide | 103 | $2,502 | $24 |
| Pravastatin | 117 | $2,337 | $20 |
| Pindolol | 26 | $2,274 | $87 |
| Nitroglycerin | 25 | $2,274 | $91 |
| Isosorbide Mononitrate Er | 66 | $2,241 | $34 |
| Midodrine | 13 | $2,099 | $161 |
| Eplerenone | 15 | $1,912 | $127 |
| Propranolol Hcl Er | 16 | $1,861 | $116 |
| Prazosin | 13 | $1,626 | $125 |
| Verapamil Er Pm | 19 | $1,595 | $84 |
| Losartan | 164 | $1,571 | $10 |
| Enoxaparin | 17 | $1,490 | $88 |
| Carvedilol | 142 | $1,280 | $9 |
| Isosorbide Dinitrate | 11 | $1,241 | $113 |
| Levoxyl | 46 | $1,171 | $25 |
| Losartan-Hydrochlorothiazide | 99 | $1,161 | $12 |
| Furosemide | 231 | $1,132 | $5 |
| Propranolol | 24 | $1,005 | $42 |
| Klor-Con Sprinkle | 37 | $985 | $27 |
| Metoprolol | 151 | $973 | $6 |
| Fenofibrate | 17 | $961 | $57 |
| Pantoprazole | 64 | $914 | $14 |
| Simvastatin | 86 | $880 | $10 |
| Propafenone | 21 | $832 | $40 |
| Digox | 14 | $705 | $50 |
| Digoxin | 25 | $684 | $27 |
| Spironolactone | 73 | $670 | $9 |
| Amiodarone | 49 | $614 | $13 |
| Lisinopril | 72 | $614 | $9 |
| Atenolol | 61 | $603 | $10 |
| Metolazone | 15 | $559 | $37 |
| Dilt-Xr | 14 | $508 | $36 |
| Triamterene-Hydrochlorothiazid | 37 | $499 | $13 |
| Hydralazine | 28 | $449 | $16 |
| Doxazosin Mesylate | 13 | $380 | $29 |
| Omeprazole | 14 | $373 | $27 |
| Clonidine | 30 | $301 | $10 |
| Ranitidine | 20 | $259 | $13 |
| Chlorthalidone | 13 | $248 | $19 |
| Alprazolam | 16 | $146 | $9 |
| Lovastatin | 12 | $141 | $12 |
| Benazepril-Hydrochlorothiazide | 12 | $132 | $11 |
| Lisinopril-Hydrochlorothiazide | 17 | $123 | $7 |
| Verapamil | 11 | $113 | $10 |
| Bisoprolol | 13 | $98 | $8 |
| Famotidine | 19 | $69 | $4 |
| Amoxicillin | 22 | $66 | $3 |
2016: 86 drugs
| Eliquis | 184 | $102,035 | $555 |
| Bystolic | 443 | $101,823 | $230 |
| Zetia | 65 | $44,336 | $682 |
| Crestor | 68 | $34,492 | $507 |
| Xarelto | 54 | $26,441 | $490 |
| Ranexa | 36 | $21,347 | $593 |
| Benicar Hct | 62 | $20,719 | $334 |
| Vascepa | 57 | $18,573 | $326 |
| Synthroid | 259 | $16,344 | $63 |
| Tribenzor | 38 | $16,059 | $423 |
| Multaq | 18 | $14,742 | $819 |
| Benicar | 34 | $14,590 | $429 |
| Vytorin | 30 | $14,182 | $473 |
| Entresto | 28 | $11,754 | $420 |
| Savaysa | 23 | $11,343 | $493 |
| Omega-3 Acid Ethyl Esters | 43 | $10,570 | $246 |
| Welchol | 38 | $10,355 | $273 |
| Metoprolol | 277 | $9,635 | $35 |
| Tirosint | 60 | $9,216 | $154 |
| Pradaxa | 13 | $8,996 | $692 |
| Atorvastatin | 470 | $8,964 | $19 |
| Valsartan | 138 | $8,003 | $58 |
| Livalo | 18 | $7,877 | $438 |
| Potassium Chloride | 120 | $6,166 | $51 |
| Edarbi | 29 | $6,031 | $208 |
| Diltiazem 24hr Er | 156 | $5,956 | $38 |
| Edarbyclor | 24 | $5,821 | $243 |
| Rosuvastatin | 66 | $5,548 | $84 |
| Brilinta | 13 | $5,099 | $392 |
| Propafenone Hcl Er | 15 | $4,453 | $297 |
| Warfarin | 299 | $4,363 | $15 |
| Pravastatin | 142 | $3,835 | $27 |
| Tekturna | 12 | $3,671 | $306 |
| Sotalol | 198 | $3,670 | $19 |
| Nifedipine Er | 74 | $3,444 | $47 |
| Coreg Cr | 13 | $3,351 | $258 |
| Levothyroxine | 133 | $2,913 | $22 |
| Clopidogrel | 135 | $2,687 | $20 |
| Amlodipine Besylate | 314 | $2,611 | $8 |
| Enoxaparin | 19 | $2,592 | $136 |
| Disopyramide Phosphate | 11 | $2,421 | $220 |
| Flecainide Acetate | 99 | $2,395 | $24 |
| Cartia Xt | 90 | $2,393 | $27 |
| Bumetanide | 70 | $2,170 | $31 |
| Valsartan-Hydrochlorothiazide | 113 | $2,050 | $18 |
| Nicardipine | 15 | $1,998 | $133 |
| Propranolol Hcl Er | 13 | $1,986 | $153 |
| Hydrochlorothiazide | 205 | $1,923 | $9 |
| Pindolol | 23 | $1,790 | $78 |
| Dilt-Xr | 20 | $1,654 | $83 |
| Fenofibric Acid | 21 | $1,653 | $79 |
| Losartan | 160 | $1,640 | $10 |
| Isosorbide Mononitrate Er | 53 | $1,435 | $27 |
| Losartan-Hydrochlorothiazide | 118 | $1,327 | $11 |
| Digoxin | 47 | $1,281 | $27 |
| Verapamil Er Pm | 12 | $1,252 | $104 |
| Isosorbide Dinitrate | 15 | $1,248 | $83 |
| Nifedical Xl | 34 | $1,186 | $35 |
| Carvedilol | 127 | $1,069 | $8 |
| Diltiazem 24hr Cd | 17 | $962 | $57 |
| Simvastatin | 94 | $904 | $10 |
| Pantoprazole | 77 | $864 | $11 |
| Lisinopril | 78 | $831 | $11 |
| Furosemide | 156 | $803 | $5 |
| Omeprazole | 20 | $724 | $36 |
| Spironolactone | 58 | $693 | $12 |
| Verapamil Er | 42 | $670 | $16 |
| Metoprolol | 98 | $626 | $6 |
| Amiodarone | 49 | $616 | $13 |
| Atenolol | 68 | $611 | $9 |
| Levoxyl | 19 | $529 | $28 |
| Propranolol | 11 | $471 | $43 |
| Triamterene-Hydrochlorothiazid | 40 | $454 | $11 |
| Nitrostat | 11 | $448 | $41 |
| Hydralazine | 26 | $423 | $16 |
| Chlorthalidone | 17 | $317 | $19 |
| Lisinopril-Hydrochlorothiazide | 18 | $270 | $15 |
| Lovastatin | 16 | $219 | $14 |
| Tramadol | 40 | $218 | $5 |
| Ranitidine | 13 | $196 | $15 |
| Clonidine | 27 | $190 | $7 |
| Benazepril-Hydrochlorothiazide | 12 | $182 | $15 |
| Famotidine | 14 | $180 | $13 |
| Alprazolam | 11 | $84 | $8 |
| Amoxicillin | 19 | $79 | $4 |
| Chlorhexidine Gluconate | 14 | $28 | $2 |
2015: 86 drugs
| Bystolic | 523 | $103,866 | $199 |
| Eliquis | 130 | $69,906 | $538 |
| Zetia | 119 | $55,240 | $464 |
| Crestor | 91 | $41,174 | $452 |
| Ranexa | 44 | $21,654 | $492 |
| Benicar Hct | 77 | $20,932 | $272 |
| Synthroid | 357 | $18,403 | $52 |
| Xarelto | 38 | $17,314 | $456 |
| Tribenzor | 27 | $13,950 | $517 |
| Edecrin | 14 | $13,220 | $944 |
| Benicar | 32 | $12,712 | $397 |
| Omega-3 Acid Ethyl Esters | 38 | $11,747 | $309 |
| Vytorin | 26 | $11,258 | $433 |
| Valsartan | 126 | $11,039 | $88 |
| Vascepa | 33 | $10,539 | $319 |
| Metoprolol | 248 | $10,376 | $42 |
| Multaq | 13 | $10,291 | $792 |
| Tirosint | 64 | $8,533 | $133 |
| Atorvastatin | 451 | $8,047 | $18 |
| Welchol | 27 | $7,168 | $265 |
| Potassium Chloride | 133 | $6,253 | $47 |
| Coreg Cr | 27 | $5,868 | $217 |
| Edarbyclor | 23 | $5,828 | $253 |
| Azor | 11 | $5,495 | $500 |
| Livalo | 12 | $5,068 | $422 |
| Edarbi | 22 | $4,951 | $225 |
| Warfarin | 305 | $4,564 | $15 |
| Diovan | 16 | $4,344 | $271 |
| Savaysa | 11 | $4,182 | $380 |
| Enoxaparin | 21 | $4,053 | $193 |
| Lovaza | 12 | $3,324 | $277 |
| Levothyroxine | 133 | $3,322 | $25 |
| Nicardipine | 18 | $3,190 | $177 |
| Diltiazem 24hr Er | 82 | $3,067 | $37 |
| Brilinta | 11 | $3,048 | $277 |
| Fenofibric Acid | 21 | $3,024 | $144 |
| Tekturna | 11 | $2,968 | $270 |
| Cartia Xt | 77 | $2,959 | $38 |
| Pravastatin | 99 | $2,894 | $29 |
| Pindolol | 24 | $2,884 | $120 |
| Valsartan-Hydrochlorothiazide | 67 | $2,634 | $39 |
| Nifedipine Er | 57 | $2,459 | $43 |
| Fenofibrate | 23 | $2,373 | $103 |
| Nifedical Xl | 53 | $2,304 | $43 |
| Clopidogrel | 143 | $2,272 | $16 |
| Amlodipine Besylate | 221 | $2,266 | $10 |
| Bumetanide | 50 | $2,229 | $45 |
| Sotalol | 174 | $2,147 | $12 |
| Hydrochlorothiazide | 207 | $1,912 | $9 |
| Flecainide Acetate | 52 | $1,829 | $35 |
| Losartan-Hydrochlorothiazide | 148 | $1,663 | $11 |
| Carvedilol | 121 | $1,440 | $12 |
| Losartan | 167 | $1,321 | $8 |
| Diltiazem 24hr Cd | 18 | $1,287 | $71 |
| Amiodarone | 12 | $1,199 | $100 |
| Cholestyramine | 13 | $1,073 | $83 |
| Diltiazem Er | 31 | $1,056 | $34 |
| Isosorbide Mononitrate Er | 48 | $1,038 | $22 |
| Digox | 16 | $941 | $59 |
| Prazosin | 15 | $929 | $62 |
| Digoxin | 38 | $836 | $22 |
| Dilt-Xr | 16 | $825 | $52 |
| Simvastatin | 94 | $812 | $9 |
| Pantoprazole | 71 | $779 | $11 |
| Atenolol | 80 | $760 | $10 |
| Furosemide | 148 | $696 | $5 |
| Levoxyl | 26 | $665 | $26 |
| Lisinopril | 85 | $641 | $8 |
| Verapamil Er | 33 | $588 | $18 |
| Liothyronine | 18 | $550 | $31 |
| Spironolactone | 45 | $473 | $11 |
| Chlorthalidone | 13 | $429 | $33 |
| Doxazosin Mesylate | 14 | $422 | $30 |
| Metoprolol | 81 | $397 | $5 |
| Nitroglycerin Patch | 13 | $336 | $26 |
| Omeprazole | 14 | $279 | $20 |
| Triamterene-Hydrochlorothiazid | 22 | $226 | $10 |
| Lisinopril-Hydrochlorothiazide | 24 | $195 | $8 |
| Ranitidine | 18 | $181 | $10 |
| Hydralazine | 20 | $176 | $9 |
| Benazepril-Hydrochlorothiazide | 13 | $152 | $12 |
| Prednisone | 17 | $141 | $8 |
| Clonidine | 26 | $138 | $5 |
| Benazepril | 15 | $118 | $8 |
| Metformin | 14 | $85 | $6 |
| Amoxicillin | 15 | $57 | $4 |
2014: 75 drugs
| Bystolic | 472 | $76,025 | $161 |
| Eliquis | 96 | $42,430 | $442 |
| Crestor | 110 | $41,139 | $374 |
| Zetia | 89 | $34,365 | $386 |
| Benicar Hct | 95 | $20,977 | $221 |
| Ranexa | 44 | $18,232 | $414 |
| Vytorin | 37 | $13,428 | $363 |
| Synthroid | 277 | $12,376 | $45 |
| Tribenzor | 33 | $11,996 | $364 |
| Atorvastatin | 493 | $11,754 | $24 |
| Benicar | 34 | $10,507 | $309 |
| Vascepa | 37 | $10,266 | $277 |
| Metoprolol | 210 | $9,466 | $45 |
| Fenofibrate | 39 | $9,254 | $237 |
| Lovaza | 23 | $8,934 | $388 |
| Diovan | 51 | $8,802 | $173 |
| Tirosint | 59 | $8,546 | $145 |
| Xarelto | 17 | $7,067 | $416 |
| Omega-3 Acid Ethyl Esters | 18 | $6,865 | $381 |
| Azor | 15 | $6,545 | $436 |
| Valsartan | 38 | $6,265 | $165 |
| Coreg Cr | 34 | $6,264 | $184 |
| Pradaxa | 17 | $5,608 | $330 |
| Clopidogrel | 192 | $5,518 | $29 |
| Warfarin | 364 | $5,356 | $15 |
| Edarbi | 26 | $5,024 | $193 |
| Edecrin | 15 | $4,659 | $311 |
| Valsartan-Hydrochlorothiazide | 45 | $4,534 | $101 |
| Potassium Chloride | 103 | $4,477 | $43 |
| Fenofibric Acid | 27 | $4,342 | $161 |
| Welchol | 19 | $4,303 | $226 |
| Edarbyclor | 15 | $4,234 | $282 |
| Nicardipine | 53 | $4,081 | $77 |
| Effient | 12 | $3,864 | $322 |
| Sotalol | 209 | $3,778 | $18 |
| Pindolol | 24 | $2,931 | $122 |
| Flecainide Acetate | 45 | $2,811 | $62 |
| Amlodipine Besylate | 204 | $2,765 | $14 |
| Levothyroxine | 148 | $2,734 | $18 |
| Losartan-Hydrochlorothiazide | 160 | $2,734 | $17 |
| Pravastatin | 79 | $2,609 | $33 |
| Diltiazem 24hr Er | 80 | $2,357 | $29 |
| Hydrochlorothiazide | 205 | $2,137 | $10 |
| Losartan | 173 | $2,080 | $12 |
| Coumadin | 12 | $1,871 | $156 |
| Carvedilol | 111 | $1,573 | $14 |
| Diltiazem Er | 25 | $1,261 | $50 |
| Nifedical Xl | 33 | $1,254 | $38 |
| Cartia Xt | 40 | $1,225 | $31 |
| Isosorbide Mononitrate Er | 46 | $1,104 | $24 |
| Digox | 26 | $1,102 | $42 |
| Diltiazem 24hr Cd | 23 | $1,086 | $47 |
| Digoxin | 23 | $1,010 | $44 |
| Verapamil Er | 43 | $973 | $23 |
| Nifedipine Er | 17 | $968 | $57 |
| Lisinopril | 100 | $885 | $9 |
| Felodipine Er | 15 | $880 | $59 |
| Simvastatin | 81 | $830 | $10 |
| Omeprazole | 17 | $797 | $47 |
| Doxazosin Mesylate | 17 | $747 | $44 |
| Spironolactone | 53 | $692 | $13 |
| Bumetanide | 28 | $633 | $23 |
| Furosemide | 131 | $539 | $4 |
| Pantoprazole | 43 | $535 | $12 |
| Atenolol | 77 | $528 | $7 |
| Levoxyl | 20 | $528 | $26 |
| Metoprolol | 83 | $514 | $6 |
| Ranitidine | 33 | $324 | $10 |
| Klor-Con 10 | 11 | $302 | $27 |
| Lisinopril-Hydrochlorothiazide | 28 | $270 | $10 |
| Amiodarone | 12 | $240 | $20 |
| Triamterene-Hydrochlorothiazid | 16 | $223 | $14 |
| Clonidine | 24 | $176 | $7 |
| Benazepril | 13 | $101 | $8 |
| Amoxicillin | 12 | $32 | $3 |
2013: 73 drugs
| Bystolic | 410 | $60,206 | $147 |
| Zetia | 124 | $35,586 | $287 |
| Crestor | 108 | $32,995 | $306 |
| Benicar Hct | 88 | $17,655 | $201 |
| Lovaza | 53 | $17,280 | $326 |
| Atorvastatin | 401 | $15,595 | $39 |
| Vytorin | 50 | $11,884 | $238 |
| Trilipix | 43 | $10,866 | $253 |
| Benicar | 49 | $9,990 | $204 |
| Diovan | 52 | $9,609 | $185 |
| Welchol | 41 | $9,439 | $230 |
| Clopidogrel | 148 | $9,261 | $63 |
| Enoxaparin | 24 | $8,939 | $372 |
| Metoprolol | 212 | $8,297 | $39 |
| Tirosint | 112 | $7,683 | $69 |
| Tribenzor | 20 | $7,321 | $366 |
| Ranexa | 14 | $6,247 | $446 |
| Fenofibrate | 17 | $6,058 | $356 |
| Warfarin | 337 | $5,721 | $17 |
| Azor | 13 | $5,226 | $402 |
| Sotalol | 224 | $5,053 | $23 |
| Coreg Cr | 30 | $4,872 | $162 |
| Vascepa | 24 | $4,515 | $188 |
| Synthroid | 133 | $4,513 | $34 |
| Diltiazem 24hr Er | 111 | $4,342 | $39 |
| Brilinta | 13 | $4,083 | $314 |
| Valsartan-Hydrochlorothiazide | 26 | $3,915 | $151 |
| Potassium Chloride | 91 | $3,876 | $43 |
| Xarelto | 13 | $3,876 | $298 |
| Livalo | 15 | $2,914 | $194 |
| Amlodipine Besylate | 177 | $2,757 | $16 |
| Losartan-Hydrochlorothiazide | 149 | $2,617 | $18 |
| Hydrochlorothiazide | 221 | $2,614 | $12 |
| Nicardipine | 55 | $2,412 | $44 |
| Losartan | 120 | $2,345 | $20 |
| Fenofibric Acid | 14 | $2,332 | $167 |
| Flecainide Acetate | 41 | $1,890 | $46 |
| Coumadin | 12 | $1,851 | $154 |
| Isosorbide Mononitrate Er | 59 | $1,820 | $31 |
| Levothyroxine | 135 | $1,470 | $11 |
| Pravastatin | 89 | $1,443 | $16 |
| Carvedilol | 83 | $1,415 | $17 |
| Fluvastatin | 12 | $1,256 | $105 |
| Pantoprazole | 53 | $1,210 | $23 |
| Cartia Xt | 14 | $1,116 | $80 |
| Propafenone | 19 | $965 | $51 |
| Diltiazem 24hr Cd | 19 | $928 | $49 |
| Lisinopril | 75 | $894 | $12 |
| Simvastatin | 61 | $858 | $14 |
| Nifedipine Er | 18 | $858 | $48 |
| Verapamil Er | 35 | $853 | $24 |
| Omeprazole | 16 | $823 | $51 |
| Diltiazem Er | 14 | $786 | $56 |
| Felodipine Er | 12 | $780 | $65 |
| Spironolactone | 61 | $758 | $12 |
| Nifedical Xl | 13 | $673 | $52 |
| Furosemide | 131 | $641 | $5 |
| Propranolol | 24 | $617 | $26 |
| Bumetanide | 42 | $560 | $13 |
| Metoprolol | 66 | $457 | $7 |
| Sotalol Af | 20 | $339 | $17 |
| Ranitidine | 33 | $331 | $10 |
| Ramipril | 12 | $321 | $27 |
| Atenolol | 56 | $301 | $5 |
| Digoxin | 27 | $248 | $9 |
| Lisinopril-Hydrochlorothiazide | 19 | $222 | $12 |
| Chlorthalidone | 13 | $202 | $16 |
| Digox | 19 | $200 | $11 |
| Triamterene-Hctz | 15 | $168 | $11 |
| Fluoxetine | 12 | $154 | $13 |
| Benazepril | 20 | $145 | $7 |
| Armour Thyroid | 12 | $93 | $8 |
| Amoxicillin | 14 | $50 | $4 |
Money from drug and device companies
$3,044 in 2025
| 2025 | 27 | 144 | None | $3,044 |
| 2024 | 20 | 113 | None | $2,397 |
| 2023 | 17 | 81 | None | $1,658 |
| 2022 | 13 | 27 | None | $702 |
| 2021 | 8 | 10 | None | $717 |
| 2020 | 20 | 95 | None | $1,744 |
| 2019 | 19 | 110 | None | $1,993 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $290 | 15 payments
|
| Pfizer | Eliquis | $272 | 14 payments
|
| Esperion Therapeutics | Nexletol | $239 | 13 payments
|
| Novartis Pharmaceuticals | Leqvio | $231 | 20 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $211 | 10 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $159 | 6 payments
|
See all 144 published payments
| Inspire Medical Systems | Meals · 2025-12-19 | Inspire | $34 |
| Scpharmaceuticals | Meals · 2025-12-16 | Furoscix | $25 |
| Esperion Therapeutics | Meals · 2025-12-12 | Nexletol | $25 |
| Abbvie | Meals · 2025-12-11 | Synthroid | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-10 | Eliquis | $9 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-08 | Jardiance | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-05 | Kerendia | $24 |
| Amgen | Meals · 2025-12-04 | Repatha | $25 |
| Scpharmaceuticals | Meals · 2025-12-03 | Furoscix | $34 |
| Philips North America | Meals · 2025-12-02 | Mcot | $8 |
| Philips North America | Meals · 2025-12-02 | Mcot | $42 |
| Azurity Pharmaceuticals | Meals · 2025-12-01 | Edarbyclor | $38 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-21 | Eliquis | $29 |
| AGEPHA Pharma FZ | Meals · 2025-11-20 | Lodoco | $22 |
| Abbvie | Meals · 2025-11-19 | Synthroid | $12 |
| Alnylam Pharmaceuticals | Meals · 2025-11-19 | Amvuttra | $17 |
| Baxter Healthcare | Meals · 2025-11-18 | Hillrom - Cardiac Ambulatory Monitor | $33 |
| Esperion Therapeutics | Meals · 2025-11-17 | Nexletol | $24 |
| Merck Sharp & Dohme | Meals · 2025-11-13 | Capvaxive | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-12 | Eliquis | $16 |
| Novo Nordisk | Meals · 2025-11-12 | Wegovy | $20 |
| Heartflow | Meals · 2025-11-11 | Ffrct | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-05 | Eliquis | $16 |
| Novo Nordisk | Meals · 2025-11-04 | Wegovy | $5 |
| Novo Nordisk | Meals · 2025-11-04 | Wegovy | $26 |
| Esperion Therapeutics | Meals · 2025-11-01 | Nexletol | $8 |
| Pfizer | Meals · 2025-10-31 | Prevnar 20 | $29 |
| GlaxoSmithKline | Meals · 2025-10-30 | Arexvy | $27 |
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Leqvio | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-27 | Kerendia | $33 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-22 | Jardiance | $32 |
| Lilly USA | Meals · 2025-10-20 | Mounjaro | $14 |
| Esperion Therapeutics | Meals · 2025-10-17 | Nexletol | $22 |
| Abbvie | Meals · 2025-10-15 | Synthroid | $12 |
| Novo Nordisk | Meals · 2025-10-13 | Wegovy | $11 |
| BridgeBio Pharma | Meals · 2025-10-11 | Attruby | $20 |
| Novartis Pharmaceuticals | Meals · 2025-10-10 | Leqvio | $5 |
| Scpharmaceuticals | Meals · 2025-10-08 | Furoscix | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-07 | Eliquis | $25 |
| Pfizer | Meals · 2025-10-01 | Eliquis | $21 |
| Abbvie | Meals · 2025-09-23 | Synthroid | $27 |
| Novartis Pharmaceuticals | Meals · 2025-09-22 | Leqvio | $6 |
| Merck Sharp & Dohme | Meals · 2025-09-22 | Verquvo | $27 |
| Esperion Therapeutics | Meals · 2025-09-18 | Nexletol | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-15 | Kerendia | $21 |
| BridgeBio Pharma | Meals · 2025-09-12 | Attruby | $48 |
| Novo Nordisk | Meals · 2025-09-09 | Wegovy | $28 |
| Bayer Healthcare Pharmaceuticals | Education · 2025-09-09 | Kerendia | $20 |
| GlaxoSmithKline | Meals · 2025-09-05 | Arexvy | $22 |
| Cleerly | Meals · 2025-09-03 | Cleerly Ischemia | $30 |
| Esperion Therapeutics | Meals · 2025-09-03 | Nexletol | $6 |
| Alnylam Pharmaceuticals | Meals · 2025-08-29 | Amvuttra | $37 |
| Pfizer | Meals · 2025-08-28 | Eliquis | $26 |
| Novartis Pharmaceuticals | Meals · 2025-08-26 | Leqvio | $5 |
| Merck Sharp & Dohme | Meals · 2025-08-26 | Verquvo | $25 |
| GlaxoSmithKline | Meals · 2025-08-22 | Shingrix | $17 |
| Novo Nordisk | Meals · 2025-08-21 | Wegovy | $17 |
| Amgen | Meals · 2025-08-21 | Repatha | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-20 | Eliquis | $24 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $8 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $8 |
| Novo Nordisk | Meals · 2025-08-19 | Wegovy | $1 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-15 | Farxiga | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-14 | Kerendia | $31 |
| Esperion Therapeutics | Meals · 2025-08-07 | Nexletol | $28 |
| Abbvie | Meals · 2025-08-06 | Synthroid | $21 |
| Novartis Pharmaceuticals | Meals · 2025-08-05 | Leqvio | $10 |
| Novartis Pharmaceuticals | Meals · 2025-08-01 | Leqvio | $33 |
| Novo Nordisk | Meals · 2025-07-29 | Wegovy | $34 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-24 | Jardiance | $30 |
| Azurity Pharmaceuticals | Meals · 2025-07-22 | Edarbi | $28 |
| Alnylam Pharmaceuticals | Meals · 2025-07-19 | Amvuttra | $38 |
| Boston Scientific | Meals · 2025-07-18 | Watchman Flx | $28 |
| Philips North America | Meals · 2025-07-16 | Mcot | $4 |
| Merck Sharp & Dohme | Meals · 2025-07-14 | Verquvo | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-11 | Eliquis | $23 |
| Novartis Pharmaceuticals | Meals · 2025-07-11 | Leqvio | $8 |
| Novartis Pharmaceuticals | Meals · 2025-07-11 | Leqvio | $6 |
| Novartis Pharmaceuticals | Meals · 2025-07-08 | Leqvio | $6 |
| Philips North America | Meals · 2025-07-08 | Mcot | $6 |
| Philips North America | Meals · 2025-07-08 | Mcot | $49 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-02 | Kerendia | $29 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Leqvio | $6 |
| Pfizer | Meals · 2025-07-01 | Vyndaqel | $28 |
| Pfizer | Meals · 2025-06-30 | Vyndaqel | $6 |
| Scpharmaceuticals | Meals · 2025-06-26 | Furoscix | $23 |
| Pfizer | Meals · 2025-06-25 | Eliquis | $16 |
| Novo Nordisk | Meals · 2025-06-21 | Ozempic | $19 |
| Novo Nordisk | Meals · 2025-06-20 | Wegovy | $1 |
| Esperion Therapeutics | Meals · 2025-06-20 | Nexletol | $25 |
| Philips North America | Meals · 2025-06-19 | Mcot | $34 |
| Heartflow | Meals · 2025-06-13 | Ffrct | $44 |
| Novartis Pharmaceuticals | Meals · 2025-06-11 | Leqvio | $19 |
| Amgen | Meals · 2025-06-10 | Repatha | $22 |
| Pfizer | Meals · 2025-06-06 | Vyndaqel | $8 |
| Edwards Lifesciences | Meals · 2025-06-03 | Sapien 3 Ultra Resilia | $37 |
| Merck Sharp & Dohme | Meals · 2025-05-30 | Verquvo | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-29 | Camzyos | $19 |
| Pfizer | Meals · 2025-05-28 | Eliquis | $22 |
| Lilly USA | Meals · 2025-05-21 | Mounjaro | $14 |
| Novo Nordisk | Meals · 2025-05-20 | Ozempic | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-20 | Farxiga | $16 |
| Novo Nordisk | Meals · 2025-05-17 | Ozempic | $23 |
| Esperion Therapeutics | Meals · 2025-05-17 | Nexletol | $28 |
| Novartis Pharmaceuticals | Meals · 2025-05-15 | Leqvio | $3 |
| Novartis Pharmaceuticals | Meals · 2025-05-14 | Leqvio | $7 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-01 | Lifevest | $30 |
| Novartis Pharmaceuticals | Meals · 2025-04-28 | Leqvio | $4 |
| Novo Nordisk | Meals · 2025-04-25 | Ozempic | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-23 | Jardiance | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-18 | Eliquis | $32 |
| Boston Scientific | Meals · 2025-04-17 | Watchman Flx | $23 |
| Novo Nordisk | Meals · 2025-04-16 | Ozempic | $28 |
| Novartis Pharmaceuticals | Meals · 2025-04-16 | Leqvio | $30 |
| Pfizer | Meals · 2025-04-11 | Eliquis | $26 |
| Abbvie | Meals · 2025-04-02 | Synthroid | $30 |
| Esperion Therapeutics | Meals · 2025-04-01 | Nexletol | $1 |
| Esperion Therapeutics | Meals · 2025-04-01 | Nexletol | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-26 | Farxiga | $24 |
| Novartis Pharmaceuticals | Meals · 2025-03-24 | Leqvio | $4 |
| Pfizer | Meals · 2025-03-24 | Vyndaqel | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-20 | Eliquis | $19 |
| Abbvie | Meals · 2025-03-20 | Synthroid | $10 |
| Amgen | Meals · 2025-03-19 | Repatha | $20 |
| Novo Nordisk | Meals · 2025-03-08 | Ozempic | $22 |
| Octapharma USA | Meals · 2025-03-07 | Fibryga | $17 |
| Pfizer | Meals · 2025-03-05 | Paxlovid | $13 |
| Pfizer | Meals · 2025-02-27 | Eliquis | $17 |
| Novartis Pharmaceuticals | Meals · 2025-02-21 | Leqvio | $3 |
| Amgen | Meals · 2025-02-19 | Repatha | $20 |
| Edwards Lifesciences | Meals · 2025-02-14 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $23 |
| Esperion Therapeutics | Meals · 2025-02-14 | Nexletol | $7 |
| Boston Scientific | Meals · 2025-02-12 | Watchman Flx | $32 |
| Novartis Pharmaceuticals | Meals · 2025-02-06 | Leqvio | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-04 | Farxiga | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-03 | Jardiance | $22 |
| Esperion Therapeutics | Meals · 2025-01-31 | Nexletol | $22 |
| Pfizer | Meals · 2025-01-30 | Eliquis | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-23 | Farxiga | $28 |
| Abbvie | Meals · 2025-01-22 | Synthroid | $16 |
| Pfizer | Meals · 2025-01-20 | Vyndaqel | $21 |
| Merck Sharp & Dohme | Meals · 2025-01-15 | Verquvo | $21 |
| Boston Scientific | Meals · 2025-01-13 | Watchman Flx | $18 |
| Heartflow | Meals · 2025-01-03 | Ffrct | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,397
| AstraZeneca Pharmaceuticals LP | Farxiga | $365 | 13 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $325 | 21 payments
|
| Esperion Therapeutics | Nexletol | $241 | 12 payments
|
| Novartis Pharmaceuticals | Entresto | $230 | 11 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $168 | 2 payments
|
| Amgen | Repatha | $157 | 9 payments
|
| Merck Sharp & Dohme | Verquvo | $151 | 6 payments
|
| Pfizer | Eliquis | $148 | 9 payments
|
| Abbvie | Synthroid | $99 | 4 payments
|
| Boston Scientific | Watchman Flx | $90 | 4 payments
|
| Lexicon Pharmaceuticals | None | $82 | 4 payments
|
| Novo Nordisk | Ozempic | $77 | 3 payments
|
| Heartflow | Ffrct | $68 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $49 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $35 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $29 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
| Cleerly | Cleerly Ischemia | $16 | 1 payment
|
2023: $1,658
| Merck Sharp & Dohme | Verquvo | $220 | 10 payments
|
| Amgen | Repatha | $204 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $203 | 7 payments
|
| Novartis Pharmaceuticals | Leqvio | $193 | 10 payments
|
| Pfizer | Eliquis | $166 | 10 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $136 | 5 payments
|
| Lexicon Pharmaceuticals | Inpefa | $124 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $90 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $60 | 3 payments
|
| Boston Scientific | Watchman Flx | $54 | 3 payments
|
| Alnylam Pharmaceuticals | Onpattro | $49 | 2 payments
|
| Esperion Therapeutics | Nexletol | $46 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $34 | 1 payment
|
| Amarin Pharma | Vascepa | $22 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $18 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $17 | 1 payment
|
2022: $702
| Biotronik | Rivacor 7 Dr-T | $159 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $129 | 8 payments
|
| Alnylam Pharmaceuticals | Onpattro | $120 | 4 payments
|
| Pfizer | Eliquis | $56 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $48 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $37 | 2 payments
|
| Amgen | Repatha | $31 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $25 | 1 payment
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $17 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $16 | 1 payment
|
2021: $717
| Welch Allyn | Spot Vital Signs 4400 Device | $533 | 1 payment
|
| Esperion Therapeutics | Nexletol | $43 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $31 | 2 payments
|
| Lundbeck | Northera | $24 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| Boston Scientific | Watchman | $23 | 1 payment
|
| Abbott Laboratories | Mitraclip System | $21 | 1 payment
|
| Arbor Pharmaceuticals | Edarbyclor | $18 | 1 payment
|
2020: $1,744
| Kowa Pharmaceuticals America | Livalo | $416 | 26 payments
|
| Amgen | Repatha | $289 | 12 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $232 | 13 payments
|
| Janssen Pharmaceuticals | Xarelto | $146 | 7 payments
|
| Arbor Pharmaceuticals | Edarbyclor | $133 | 11 payments
|
| Amarin Pharma | Vascepa | $62 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $58 | 3 payments
|
| Lundbeck | Northera | $55 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $47 | 2 payments
|
| Akcea Therapeutics | Tegsedi | $47 | 2 payments
|
| AbbVie | Synthroid | $40 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $35 | 2 payments
|
| Esperion Therapeutics | Nexletol | $33 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $30 | 1 payment
|
| Boston Scientific | Watchman | $28 | 1 payment
|
| Biotronik | None | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $23 | 1 payment
|
| Abbott Laboratories | Mitra Clip System | $19 | 1 payment
|
| IBSA Pharma | Tirosint | $14 | 1 payment
|
| Philips Electronics North America | (7999) Src Undivided | $12 | 1 payment
|
2019: $1,993
| Kowa Pharmaceuticals America | Livalo | $308 | 19 payments
|
| Amgen | Repatha | $258 | 12 payments
|
| Janssen Pharmaceuticals | Xarelto | $195 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $184 | 26 payments
|
| Akcea Therapeutics | Tegsedi | $173 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $166 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $163 | 8 payments
|
| Abiomed | Impella | $125 | 1 payment
|
| AbbVie | Synthroid | $95 | 5 payments
|
| Pfizer | Eliquis | $84 | 4 payments
|
| Lundbeck | Northera | $47 | 2 payments
|
| Arbor Pharmaceuticals | Edarbyclor | $43 | 2 payments
|
| Amarin Pharma | Vascepa | $37 | 2 payments
|
| Biotronik | None | $33 | 1 payment
|
| Relypsa | Veltassa | $24 | 1 payment
|
| Astellas Pharma US | Lexiscan | $22 | 1 payment
|
| Boston Scientific | Watchman | $13 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $11 | 1 payment
|
| Allergan | Vraylar | $11 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 84.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 2,191 |
| Asked about alcoholPatients screened for unhealthy alcohol use, with counseling if needed | 1%That's few of the people this applied to. | 2,094 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 39%That's less than half. | 2,094 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 67%That's more than half. | 1,638 |
| Medications listed in the chartVisits where the current medication list was documented | 99%That's most of the people this applied to. | 6,939 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 3,590 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1184650772
- Licence
- CA A56316California A56316: Current · expires 2028-06-30
- Group
- Durga Madala M D Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2516 Samaritan Dr, Suite A, San Jose, CA, 95124
- NPI first listed
- 2006-06-24
- NPI last updated
- 2013-03-21
This is when the NPI record was last certified, not a medical board exam.